Cipra Tablet 40mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Huons Life Sciences Co., Ltd.
MFDS item code 202002254 · Approved 2020.03.31
This product's status changed to Approval withdrawn on 2024.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (reflux, ulcers, etc.), gastrointestinal disorders caused by anti-inflammatory analgesics, and Helicobacter pylori infection
This medication is used for the treatment of gastroesophageal reflux disease, especially for erosive esophagitis and for long-term maintenance therapy to prevent the recurrence of esophagitis. It is also effective in relieving symptoms of gastroesophageal reflux disease without esophagitis. It is utilized in combination with antibiotics for the treatment and prevention of recurrence of duodenal and peptic ulcers caused by Helicobacter pylori infection. It helps in the short-term treatment of upper gastrointestinal symptoms that may occur during the use of non-steroidal anti-inflammatory drugs and also treats gastric ulcers as well as preventing gastric and duodenal ulcers. Additionally, it is used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after preventing rebleeding due to gastric or duodenal ulcers. Overall, it effectively improves various symptoms and diseases related to gastrointestinal disorders.
Swallow this drug with a liquid such as water; do not chew or crush it. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical trials lasting longer than 4 weeks have not been conducted. 4) Patients requiring continued nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should subsequently be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided and taken twice daily. 6) Maintenance therapy following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction of prevention of rebleeding from gastric or duodenal ulcers. 4. Renal impairment No dosage adjustment is necessary. Use with caution because there is limited experience in patients with severe renal failure. 5. Hepatic impairment No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Elderly patients No dosage adjustment is necessary.
2. Adolescents aged 12 years or older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. For patients whose esophagitis has not healed or whose symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: Once symptoms have resolved, control subsequent symptoms by administering 20 mg once daily. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended for patients at high risk of developing gastric or duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 3. Pediatric patients under 12 years of age There is no experience with administration of this drug to pediatric patients under 12 years of age.
This medication should not be administered to certain patients. It should not be used in patients who are hypersensitive to this drug, its ingredients, or benzimidazole derivatives or have a history of such reactions. Patients with hypersensitivity to antibiotics like amoxicillin or clarithromycin used in combination to eradicate Helicobacter pylori should also not take this medication. Administration is prohibited in certain patients including those on specific heart-related medications or antiviral agents, breastfeeding women, and patients with myocardial infarction. Various adverse reactions may occur when using this medication. Commonly reported side effects include headaches, abdominal pain, diarrhea, constipation, and drowsiness; less frequently, blood abnormalities, allergic reactions, liver dysfunction, skin rashes, and muscle pain may be observed. Particularly, hypomagnesemia may rarely occur, which can cause serious electrolyte imbalances, requiring caution. This medication increases the risk of bacterial infections in the stomach due to its action of suppressing gastric acid secretion. Moreover, long-term use may increase the risk of fractures, so patients at risk for osteoporosis require regular monitoring. Attention should be paid to drug interactions during medication use. In particular, when combined with digoxin, warfarin, methotrexate, antiviral agents, and certain antibiotics, there might be adverse effects due to changes in drug concentrations, so consultation with healthcare professionals is needed. There is limited safety data on this drug during pregnancy, so caution is advised when administering it to pregnant women; breastfeeding women are recommended not to take this medication. In cases of overdose, since no specific antidote exists, symptomatic treatment is required, and this medication has a high protein binding rate, which is not removed by dialysis. This medication should be kept out of reach of children, and transferring it to another container should be avoided for maintaining quality and safety.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, taste disturbance, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal chest pain, facial swelling, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid gland enlargement, irritable bowel syndrome, constipation worsening, dyspepsia, dysphagia, gastrointestinal motility disorder, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypochromic anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, arthritis exacerbation, arthropathy, convulsions, fibromyalgia syndrome, hernia, polymyalgia rheumatica, arthralgia, anorexia, apathy, increased appetite, confusion, depression exacerbation, hypertonia, anxiety, sensory impairment, erectile dysfunction, insomnia, migraine, migraine exacerbation, sleep disorders, tremor, dizziness, visual field deficit, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, asthma exacerbation, cough, shortness of breath, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, dysosmia, taste loss, taste distortion, urinary disorders, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyps, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, asthenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture, and must be kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication for a longer period.
Pink round film-coated tablet
28 tablets/PTP [14 tablets/Alu-Alu×2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Huons Life Sciences Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.